- The vaccine was registered under the emergency use;
- Argentine regulator approval is based on the results of Phase III clinical trials in Russia.
Russia’s sovereign wealth fund said on Wednesday that the Sputnik V coronavirus vaccine has been approved for use by Argentina’s regulators, reported Reuters.
READ ALSO: COVID-19 vaccinations to begin in Mexico and Chile on Thursday
“Argentina was the first country in Latin America to officially register Sputnik V,” the Russian Direct Investment Fund (RDIF) said in a statement.
READ ALSO: Oxford-AstraZeneca vaccine to arrive in Brazil in February, says President of Brazil’s Fiocruz Institute
“The vaccine was registered under the emergency use authorization procedure and was approved by the regulator, ANMAT, based on the results of Phase III clinical trials in Russia, without additional trials in Argentina,” it said.